These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 24481173)
1. A canine model of Alzheimer's disease generated by overexpressing a mutated human amyloid precursor protein. Lee GS; Jeong YW; Kim JJ; Park SW; Ko KH; Kang M; Kim YK; Jung EM; Moon C; Hyun SH; Hwang KC; Kim NH; Shin T; Jeung EB; Hwang WS Int J Mol Med; 2014 Apr; 33(4):1003-12. PubMed ID: 24481173 [TBL] [Abstract][Full Text] [Related]
2. Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor. Pu YZ; Liang L; Fu AL; Liu Y; Sun L; Li Q; Wu D; Sun MJ; Zhang YG; Zhao BQ Curr Alzheimer Res; 2017; 14(6):668-679. PubMed ID: 27978793 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease. Lahiri DK; Ge YW; Maloney B FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276 [TBL] [Abstract][Full Text] [Related]
4. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597 [TBL] [Abstract][Full Text] [Related]
5. [Studying pathogenesis of Alzheimer's disease in a Drosophila melanogaster model: human APP overexpression in the brain of transgenic flies leads to deficit of the synaptic protein synaptotagmin]. Sarantseva SV; Bol'shakova OI; Timoshenko SI; Rodin DI; Vitek MP; Shvartsman AL Genetika; 2009 Jan; 45(1):119-26. PubMed ID: 19239106 [TBL] [Abstract][Full Text] [Related]
6. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice. Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition. Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176 [TBL] [Abstract][Full Text] [Related]
11. Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Vercauteren FG; Clerens S; Roy L; Hamel N; Arckens L; Vandesande F; Alhonen L; Janne J; Szyf M; Cuello AC Brain Res Mol Brain Res; 2004 Dec; 132(2):241-59. PubMed ID: 15582162 [TBL] [Abstract][Full Text] [Related]
12. Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Kawabata S; Higgins GA; Gordon JW Nature; 1991 Dec; 354(6353):476-8. PubMed ID: 1793460 [TBL] [Abstract][Full Text] [Related]
13. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635 [TBL] [Abstract][Full Text] [Related]
14. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131 [TBL] [Abstract][Full Text] [Related]
15. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629 [TBL] [Abstract][Full Text] [Related]
16. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a canine model of human type 2 diabetes mellitus by overexpressing phosphoenolypyruvate carboxykinase. Jeong YW; Lee GS; Kim JJ; Park SW; Ko KH; Kang M; Kim YK; Jung EM; Hyun SH; Shin T; Jeung EB; Hwang WS Int J Mol Med; 2012 Aug; 30(2):321-9. PubMed ID: 22580743 [TBL] [Abstract][Full Text] [Related]
18. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638 [TBL] [Abstract][Full Text] [Related]
19. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice. Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional activities of human elongation factor-1α and cytomegalovirus promoter in transgenic dogs generated by somatic cell nuclear transfer. Eun K; Hong N; Jeong YW; Park MG; Hwang SU; Jeong YIK; Choi EJ; Olsson PO; Hwang WS; Hyun SH; Kim H PLoS One; 2020; 15(6):e0233784. PubMed ID: 32492024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]